MedPath

The effect of okra powder on blood sugar levels in pre-diabetic patients

Phase 3
Recruiting
Conditions
Pre-diabetes.
Registration Number
IRCT20201026049154N1
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Fasting blood sugar between 100 and 125 mg per deciliter

Exclusion Criteria

Pregnancy and lactation in women
Existence of mental disorders at the same time that make it difficult to cooperate
Concomitant diseases such as heart disease, renal failure, thyroid disease, inflammatory diseases and allergies
Taking non-steroidal anti-inflammatory drugs
Taking steroid drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduce fasting blood sugar. Timepoint: At the beginning of the study and after 8 weeks of consumption of okra powder. Method of measurement: Blood sample analysis.
Secondary Outcome Measures
NameTimeMethod
HbA1C. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Blood sample analysis.;Measurement of interleukin 6 (one of the inflammatory factors) in the blood. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Blood sample analysis.;Measurement of blood TNF-. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Blood sample analysis.;Evaluation of miR-15a expression (one of the diabetes-related miRs). Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: With Real-time pcr method.;Expression of miR-126 expression (one of the diabetes-related miRs). Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: With Real-time pcr method.
© Copyright 2025. All Rights Reserved by MedPath